Effexor and Desferal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Desferal (deferoxamine mesylate). Common drug interactions include abdominal pain upper among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Desferal. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Desferal?

Desferal has active ingredients of deferoxamine mesylate. It is often used in iron overload. eHealthMe is studying from 2,248 Desferal users. Check the latest studies of Desferal.



On Jul, 12, 2026

14 people who take Effexor and Desferal together, and have interactions are studied.

Effexor and Desferal drug interactions.

What are the common drug interactions of Effexor and Desferal, by gender? *:

female:

  1. Abdominal pain upper
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood bilirubin increased
  5. Blood triglycerides increased
  6. Bone marrow failure
  7. Duodenal ulcer
  8. Gastritis (inflammation of stomach)
  9. Histiocytosis haematophagic
  10. Pancreatitis acute (sudden inflammation of pancreas)

male:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Reticulocyte count increased
  4. Venous thrombosis (blood clot (thrombus) that forms within a vein)
  5. Back pain
  6. Brain natriuretic peptide increased
  7. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  8. Conjunctival pallor (a pale colour of conjunctiva)
  9. Conjunctivitis (pink eye)
  10. Pain

What are the common drug interactions of Effexor and Desferal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood bilirubin increased
  5. Duodenal ulcer
  6. Gastritis (inflammation of stomach)
  7. Anaemia (lack of blood)
  8. Arthralgia (joint pain)
  9. Back pain
  10. Conjunctival pallor (a pale colour of conjunctiva)

30-39:

n/a

40-49:

  1. Paroxysmal nocturnal haemoglobinuria (haemoglobin in the urine)

50-59:

  1. Urinary tract infection

60+:

  1. Blood triglycerides increased
  2. Bone marrow failure
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Venous thrombosis (blood clot (thrombus) that forms within a vein)
  5. Histiocytosis haematophagic
  6. Brain natriuretic peptide increased
  7. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  8. Conjunctivitis (pink eye)
  9. Macrophages increased (increased immune cells that eats foreign material and dead cells)
  10. Pulmonary embolism (blockage of the main artery of the lung)

What are the existing conditions these people have? *

  1. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 14.29%
  2. Headache (pain in head): 2 people, 14.29%
  3. Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 2 people, 14.29%
  4. Blood Iron Increased: 2 people, 14.29%
  5. Pain: 1 person, 7.14%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.14%
  7. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
  8. Constipation: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Desferal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Desferal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Desferal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Desferal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and deferoxamine mesylate (the active ingredients of Effexor and Desferal, respectively), and Effexor and Desferal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: